Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 26,270
-220 (-0.83%)
Apr 2, 2026, 3:30 PM IST
Abbott India Market Cap
Abbott India has a market cap or net worth of 558.33 billion as of April 2, 2026. Its market cap has decreased by -14.24% in one year.
Market Cap
558.33B
Enterprise Value
536.73B
Revenue
68.24B
Ranking
n/a
PE Ratio
36.63
Stock Price
26,270.00
Market Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 558.33B, an increase of 11,606.84%. That is a compound annual growth rate of 21.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 562.93B | -8.87% |
| Dec 31, 2025 | 617.71B | -2.27% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipla | 988.89B |
| Zydus Lifesciences | 876.63B |
| Mankind Pharma | 828.05B |
| Aurobindo Pharma | 757.60B |
| Alkem Laboratories | 633.57B |
| Glenmark Pharmaceuticals | 601.57B |
| Laurus Labs | 535.92B |
| Ipca Laboratories | 406.23B |